Esophageal Candidiasis
📧 Sign up to get email alerts when something new happens for Esophageal Candidiasis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-02-19FDA Approved: VFEND — Supplemental Application (Roerig)
FDA approved a supplemental application for Vfend (voriconazole) submitted by Roerig.
-
FDA approval · 2026-01-28FDA Approved: VFEND — Supplemental Application (Roerig)
FDA approved a supplemental application for VFEND (voriconazole) submitted by Roerig.
-
FDA approval · 2026-01-21FDA Approved: MICAFUNGIN — Original Application (Hisun Pharmaceuticals USA, Inc.)
FDA approved Hisun Pharmaceuticals USA, Inc.'s original application for micafungin as a generic injectable antifungal. The approval covers u…
-
FDA approval · 2026-01-14FDA Approved: FLUCONAZOLE IN SODIUM CHLORIDE — Supplemental Application (Hospira, Inc.)
The FDA approved Hospira's supplemental application for Fluconazole in Sodium Chloride (intravenous formulation), adding this generic IV flu…
-
FDA approval · 2025-11-14FDA Approved: VORICONAZOLE — Original Application (Hainan Poly Pharm. Co., Ltd.)
The FDA approved a generic Voriconazole product from Hainan Poly Pharm. Co., Ltd. via an Original Application (ANDA 220043). It covers voric…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-07-23FDA Approved: MICAFUNGIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Micafungin (Hikma Pharmaceuticals USA Inc.), leading to changes/updates approved for this antifu…
-
FDA approval · 2025-07-18FDA Approved: CASPOFUNGIN ACETATE — Original Application (Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.)
The FDA approved Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.'s caspofungin acetate as an original generic application (ANDA) for mark…
-
FDA approval · 2025-04-25FDA Approved: FLUCONAZOLE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for fluconazole by Hikma Pharmaceuticals USA Inc., advancing the approval of this generic antifu…
-
FDA approval · 2025-04-03FDA Approved: MICAFUNGIN — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's original ANDA for generic micafungin for the treatment of invasive candidiasis, candidemia, esophageal candidiasis, …
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug [Phase 1]
Phase 1 study of Mycamine in children to evaluate safety and drug blood levels in fungal infections; the trial has completed.
-
FDA approval · 2024-06-25FDA Approved: FLUCONAZOLE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Fluconazole from Dr. Reddy's Laboratories Limited (ANDA 076658).
-
FDA approval · 2024-05-29FDA Approved: MICAFUNGIN — Original Application (Biocon Pharma Inc.)
FDA approved Biocon Pharma Inc.'s original ANDA for micafungin, a generic antifungal. The approval covers indications including candidiasis …
-
FDA approval · 2024-04-03FDA Approved: VORICONAZOLE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original application for Voriconazole (generic), confirming its status as an approved generic antifunga…
-
FDA approval · 2023-10-24FDA Approved: FLUCONAZOLE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approves a supplemental application for fluconazole submitted by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2023-09-29FDA Approved: MICAFUNGIN IN SODIUM CHLORIDE — Original Application (Baxter Healthcare Corporation)
FDA approved a new intravenous micafungin sodium formulation under Baxter's Original Application NDA, expanding antifungal treatment options…
-
FDA approval · 2023-08-08FDA Approved: VORICONAZOLE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for voriconazole from Zydus Lifesciences Limited, indicating an approval of the supplemental submiss…
-
FDA approval · 2023-07-14FDA Approved: FLUCONAZOLE — Supplemental Application (Baxter Healthcare Company)
FDA approved Baxter Healthcare Company's supplemental application for fluconazole (ANDA076766). This action confirms authorization of a gene…
-
FDA approval · 2023-03-17FDA Approved: FLUCONAZOLE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for fluconazole submitted by Rising Pharma Holdings, Inc., indicating approval of a generic formulat…
-
FDA approval · 2023-03-09FDA Approved: VORICONAZOLE — Original Application (UBI Pharma Inc.)
FDA approved a generic version of voriconazole (UBI Pharma Inc.) via Original Application. The approval covers treatment of certain invasive…
-
FDA approval · 2022-12-14FDA Approved: VORICONAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Voriconazole from Sandoz Inc, approving a generic version of the antifungal medication.
-
FDA approval · 2022-10-24FDA Approved: MICAFUNGIN — Original Application (Northstar Rx LLC.)
FDA approved Northstar Rx LLC's original application for micafungin, a generic antifungal, for the treatment of invasive candidiasis includi…
-
FDA approval · 2022-09-28FDA Approved: MICAFUNGIN — Original Application (Meitheal Pharmaceuticals Inc.)
The FDA approved Meitheal Pharmaceuticals' original application for micafungin sodium (micafungin) injection, a generic antifungal, for trea…
-
FDA approval · 2022-08-16FDA Approved: VORICONAZOLE — Supplemental Application (Xellia Pharmaceuticals USA LLC)
FDA approved a supplemental application for Voriconazole by Xellia Pharmaceuticals USA LLC.
-
FDA approval · 2022-07-28FDA Approved: POSACONAZOLE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for posaconazole delayed-release (POSACONAZOLE DELAYED-RELEASE) from Chartwell RX, LLC, updating its…
-
FDA approval · 2022-06-13FDA Approved: VORICONAZOLE — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for Voriconazole from Zydus Lifesciences Limited, updating the approval for this generic antifun…